{"database": "lobbying", "table": "lobbying_activities", "rows": [[664396, "ddd33819-a9e7-43ef-9ca7-35438d96d4a6", "Q3", "MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY", 62277, "MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY", 2008, "third_quarter", "PHA", "H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics\nH. R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007, follow-on biologics\nH. R. 5629, Pathway for Biosimilars Act\nS. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics\nS. 2029, Physician Payments Sunshine Act of 2007\nS. 623, Access to Life-Saving Medicine Act, follow-on biologics", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 340000, 0, 0, "2008-10-14T10:56:45-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["664396"], "units": {}, "query_ms": 26.739884982816875, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}